Repare Therapeutics Inc. Marketable Securities, Current in USD from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Repare Therapeutics Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2020 to Q3 2025.
  • Repare Therapeutics Inc. Marketable Securities, Current for the quarter ending September 30, 2025 was $39.8M, a 59.8% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)

Repare Therapeutics Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $39.8M -$59.1M -59.8% Sep 30, 2025 10-Q 2025-11-14
Q2 2025 $41.8M -$86.5M -67.4% Jun 30, 2025 10-Q 2025-08-08
Q1 2025 $39.8M -$94M -70.3% Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $68.1M -$44.3M -39.4% Dec 31, 2024 10-Q 2025-11-14
Q3 2024 $98.9M -$43.8M -30.7% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $128M -$36.8M -22.3% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $134M -$58.9M -30.6% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $112M -$72.1M -39.1% Dec 31, 2023 10-K 2025-03-03
Q3 2023 $143M -$72.5M -33.7% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $165M +$159M +2540% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $193M +$186M +2851% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $184M +$177M +2379% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $215M +$208M +2891% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $6.26M -$905K -12.6% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $6.53M -$969K -12.9% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $7.44M -$87K -1.16% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $7.19M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $7.16M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $7.5M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $7.53M Dec 31, 2020 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.